RVAC Medicines has formed a group of highly skilled professionals specializing in mRNA, immunizations, and lipid nanoparticle (LNP) technologies. We are dedicated to developing a range of groundbreaking products for the treatment of infectious ailments and other unmet medical needs. Through our endeavors, RVAC Medicines aims to enhance the defenses of ASEAN nations against COVID-19 and SARS-CoV2 mutations, while also creating innovative therapies for various infectious diseases. In pursuit of this objective and the realization of our targets, we are establishing state-of-the-art GMP manufacturing facilities that will propel our platform technologies forward.